The human milk fortifier market is expected to grow from US$ 274.67 million in 2022 to US$ 566.35 million by 2030; it is estimated to register a CAGR of 9.6% from 2022 to 2030.
Human milk fortifiers are nutritional supplements added to human milk to provide additional calories, electrolytes, and vitamins to infants. It is commonly prescribed to preterm babies in the neonatal intensive care unit (NICU) to ensure nutritional intake and improve overall development and growth. In addition, babies with low weight are also prescribed human milk fortifiers.
The human milk fortifier market is segmented into powder and liquid based on form. The powder segment is expected to register a higher CAGR during the forecast period. Human milk fortifiers in the powdered form supplement and enhance the nutritional content of breast milk. Fortified breast milk is prescribed to premature or medically fragile infants. People prefer powdered human milk fortifiers for convenience in storage, handling, and preparation. Moreover, they are easier to store and transport while ensuring a longer shelf life than liquid products.
In 2022, North America accounted for the largest share of the global human milk fortifier market. The market in the region is segmented into the US, Canada, and Mexico. There has been a growing awareness among healthcare professionals and parents about the benefits of human milk fortifiers for preterm infants in North America. Human milk fortifiers are used to enhance the nutritional content of breast milk, providing essential nutrients that are often lacking in the milk of preterm mothers. As product awareness increases, more healthcare facilities and parents opt for human milk fortifiers, driving the market. North America has observed a rise in the preterm birth rate in recent years. Preterm infants are at higher risk of nutritional deficiencies and require specialized nutrition to support their growth and development. Human milk fortifiers are crucial in meeting the nutritional needs of these infants, which has led to increased demand for such products. Also, developing advanced human milk fortifiers with improved formulations and enhanced nutritional profiles has contributed to market growth. Manufacturers have invested in research and development to create fortifiers that offer optimal nutrition for preterm infants. These advancements have increased the effectiveness and acceptance of human milk fortifiers among healthcare providers and parents.
The key players operating in the global human milk fortifier market include Abbott Laboratories, NeoLacta Lifesciences Pvt Ltd, Nestle SA, Prolacta Bioscience Inc, Lead Care International Ltd, Raptakos, Brett & Co Ltd, NeoKare Nutrition Ltd, Danone SA, Neolac Inc, and Reckitt Benckiser Group Plc. Players operating in the global human milk fortifier market focus on providing high-quality products to fulfill customer demand. They also focus on strategies such as investments in research and development activities, new product launches, and expanding production capacities.
The overall global human milk fortifier market size has been derived using primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers?along with external consultants such as valuation experts, research analysts, and key opinion leaders?specializing in the human milk market.